# Splenda: Effects on Blood Glucose Concentration, Appetite Scores and Subsequent Energy Intake

> **NCT05810337** · NA · COMPLETED · sponsor: **King's College London** · enrollment: 51 (actual)

## Conditions studied

- Appetitive Behavior
- Glucose Metabolism Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** Splenda drink
- **DIETARY_SUPPLEMENT:** Maltodextrin drink
- **DIETARY_SUPPLEMENT:** High carbohydrate breakfast

## Key facts

- **NCT ID:** NCT05810337
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-18
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-03-13
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05810337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05810337, "Splenda: Effects on Blood Glucose Concentration, Appetite Scores and Subsequent Energy Intake". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05810337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*